Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Indonesia
97%
Indonesian
63%
Insulin Resistance
43%
Obesity
37%
Type 2 Diabetes Mellitus Patients
34%
Type 2 Diabetic Patients
32%
Type 1 Diabetes Mellitus (T1DM)
28%
Waist Circumference
27%
Jakarta
26%
Metabolic Syndrome
21%
Meta-analysis
21%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
21%
Pada
19%
Risk Factors
19%
Anthelmintic Treatment
17%
Helminths
17%
Body Mass Index
16%
Diabetes
16%
Cluster Randomized Trial
15%
Ramadan Fasting
15%
Systematic Meta-analysis
15%
Helminth Infection
15%
Diabetes Melitus
14%
TipE
14%
Diabetes Management
13%
Adiposity
13%
Graves' Disease
13%
Hemoglobin A1c (HbA1c)
13%
Pre-diabetes (pre-DM)
13%
COVID-19 Patients
12%
National Health Survey
12%
Metabolic Profiling
12%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
12%
Bogor
12%
Hypoglycemia
12%
Middle-aged
12%
Soil-transmitted Helminths
12%
Randomized Placebo-controlled Trial
11%
Clinical Practice Guidelines
11%
COVID-19
11%
COVID-19 Severity
11%
Fasting Plasma Glucose
11%
Adiponectin
10%
Poor Prognosis
10%
Lipid Accumulation Product
10%
Leptin
10%
Hypertension
10%
Lipid Accumulation Product Index
10%
Albendazole
10%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
88%
Diabetes
57%
Body Mass Index
30%
Systematic Review
29%
Insulin Resistance
27%
Prevalence
24%
Diabetes Mellitus
23%
COVID-19
19%
Meta-Analysis
17%
Metabolic Syndrome
15%
Helminth
14%
Type 2 Diabetes
14%
Adiponectin
13%
Impaired Glucose Tolerance
13%
Lipid Storage
13%
Non Communicable Disease
12%
Cohort Analysis
12%
Health Survey
12%
Patient Referral
12%
Leptin
12%
Homeostatic Model Assessment
12%
Ramadan Fasting
11%
Blood Glucose
11%
Cardiovascular Disease
11%
Patient with Type 2 Diabetes
10%
Helminthiasis
10%
Randomized Controlled Trial
10%
Placebo
10%
Cardiovascular System
10%
Triacylglycerol
9%
Cross Sectional Study
9%
Diseases
9%
Health Care Cost
9%
Graves' Disease
9%
Hemoglobin A1c
8%
Primary Health Care
8%
Quality of Life
8%
Glycemic Control
8%
Hypoglycemia
8%
Anthropometry
8%
Diabetic Foot Ulcer
7%
Oral Antidiabetic Agent
7%
Middle Age
7%
Diabetic Ketoacidosis
7%
C-Peptide
7%
High Fat Food
7%
Sodium Glucose Cotransporter 2 Inhibitor
7%
Latent Autoimmune Diabetes in Adults
7%
Odds Ratio
7%
Chronic Disease
7%